Ambrichor

Ambrichor provides access to biological samples for the development and regulatory validation of blood-based cancer tests. Ambrichor collects plasma samples from a high risk, asymptomatic cohort of individuals and cancer patients. Our first indication is lung cancer, in which our region has the highest incidence worldwide. The sample collection fulfils the most rigorous pre-analytical requirements of cell free nucleic acid, exosome or epitope analysis. It also fulfils the regulatory, quality control and documentation requirements of clinical validation for registration studies submitted to Notified Bodies or US Food and Drug Administration.